Welcome to our dedicated page for Perimeter Medical Imaging Ai news (Ticker: PYNKF), a resource for investors and traders seeking the latest updates and insights on Perimeter Medical Imaging Ai stock.
Perimeter Medical Imaging AI develops real-time optical coherence tomography imaging systems and artificial-intelligence tools for cancer surgery. The company’s Claire OCT+AI device has FDA premarket approval for intraoperative breast cancer margin assessment, while its S-Series OCT platform provides ultra-high-resolution cross-sectional visualization of excised tissue.
Company news commonly covers FDA regulatory milestones, product demonstrations, commercialization activity, clinical and technology updates, operating and financial results, investor conference presentations, and capital-structure actions such as private placements, warrants, and stock-option matters.
Perimeter Medical Imaging AI will host an investor webcast on June 25, 2024, at 2:00 PM ET. The event will feature presentations from CEO Adrian Mendes, CIO Andrew Berkeley, and CFO Sara Brien, focusing on key business areas. Investors can engage in a live Q&A session. To participate, pre-register at the provided link. An archived version will be accessible on the company's website.
Perimeter Medical Imaging AI reported its Q1 2024 financial results, highlighting significant progress in clinical development and commercial expansion.
The company exceeded patient enrollment expectations in its pivotal clinical trial for the B-Series OCT with ImgAssist AI, leading to a decision to expedite full enrollment by early Q4 2024. Three new placements of the S-Series OCT system were completed, boosting market presence.
Financially, operating expenses rose to $4.7 million, but net loss decreased to $2.1 million compared to Q1 2023. Cash and equivalents stood at $10.6 million as of March 31, 2024.
A conference call is scheduled for 5 pm ET to discuss the results and provide further updates.
Perimeter Medical Imaging AI, Inc. (PYNKF) will release its first quarter 2024 financial results on May 14, 2024, followed by a conference call hosted by CEO Adrian Mendes. The call will discuss the results and provide a corporate update. Investors can join the call online or via phone.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.